Clinical Trials Browser

Breast Neoplasms × glembatumumab vedotin × Clear all

NCT01997333 2019-03-08

METRIC

Phase 2 Completed

327 enrolled 17 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03326258 2018-07-18

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Phase 1/2 Withdrawn

BreastDermatologic

Uveal Melanoma, Breast Neoplasms, Melanoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT01156753 2017-07-02

EMERGE

Phase 2 Completed

Breast Neoplasms